Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 31 studies | 82% ± 21% | |
granulocyte | 3 studies | 81% ± 26% |
Insufficient scRNA-seq data for expression of TPSB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 94% | 1879.19 | 230 / 245 | 87% | 23.20 | 438 / 502 |
lung | 97% | 3391.02 | 560 / 578 | 83% | 30.75 | 957 / 1155 |
esophagus | 93% | 2852.34 | 1339 / 1445 | 72% | 15.62 | 131 / 183 |
stomach | 95% | 1991.12 | 341 / 359 | 68% | 18.10 | 195 / 286 |
bladder | 100% | 3155.14 | 21 / 21 | 61% | 16.04 | 306 / 504 |
breast | 82% | 1309.22 | 378 / 459 | 78% | 43.89 | 869 / 1118 |
intestine | 85% | 1962.83 | 824 / 966 | 66% | 15.66 | 346 / 527 |
uterus | 86% | 1417.15 | 147 / 170 | 58% | 17.89 | 265 / 459 |
pancreas | 33% | 183.98 | 109 / 328 | 87% | 36.09 | 155 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.10 | 1 / 1 |
kidney | 26% | 380.83 | 23 / 89 | 69% | 20.18 | 622 / 901 |
skin | 69% | 1842.68 | 1251 / 1809 | 22% | 4.05 | 106 / 472 |
adipose | 91% | 1962.37 | 1097 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 23.11 | 37 / 45 |
blood vessel | 45% | 384.44 | 604 / 1335 | 0% | 0 | 0 / 0 |
thymus | 11% | 74.92 | 70 / 653 | 27% | 5.74 | 165 / 605 |
liver | 15% | 76.81 | 33 / 226 | 17% | 4.17 | 71 / 406 |
adrenal gland | 1% | 3.40 | 2 / 258 | 25% | 6.19 | 58 / 230 |
ovary | 9% | 65.07 | 17 / 180 | 17% | 3.31 | 71 / 430 |
lymph node | 0% | 0 | 0 / 0 | 24% | 2.55 | 7 / 29 |
heart | 19% | 96.62 | 167 / 861 | 0% | 0 | 0 / 0 |
muscle | 13% | 65.40 | 105 / 803 | 0% | 0 | 0 / 0 |
spleen | 10% | 77.68 | 24 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 24.22 | 31 / 929 | 0% | 0 | 0 / 0 |
brain | 0% | 0.32 | 2 / 2642 | 3% | 0.37 | 21 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006508 | Biological process | proteolysis |
GO_0005615 | Cellular component | extracellular space |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | TPSB2 |
Protein name | Tryptase beta 2 TPSB2 protein Tryptase beta-2 (Tryptase-2) (EC 3.4.21.59) (Tryptase II) |
Synonyms | TPS2 |
Description | FUNCTION: Tryptase is the major neutral protease present in mast cells and is secreted upon the coupled activation-degranulation response of this cell type. May play a role in innate immunity. . |
Accessions | Q6FHB8 A0A087WUI4 ENST00000611196.4 ENST00000606293.5 P20231 ENST00000612142.1 A0A087X1U0 Q6NZY1 |